SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:umu-1680"
 

Sökning: id:"swepub:oai:DiVA.org:umu-1680" > Cisplatin-resistanc...

Cisplatin-resistance and cell death in malignant pleural mesothelioma cells

Janson, Veronica, 1974- (författare)
Umeå universitet,Institutionen för medicinsk biovetenskap
Grankvist, Kjell, Professor (preses)
Umeå universitet,Institutionen för medicinsk biovetenskap
Henriksson, Roger, Professor (preses)
Umeå universitet,Institutionen för strålningsvetenskaper
visa fler...
Behnam-Motlagh, Parviz, PhD (preses)
Umeå universitet,Institutionen för medicinsk biovetenskap
Johansson, Anders, OD (preses)
Umeå universitet,Institutionen för odontologi
Zhivotovsky, Boris, Professor (opponent)
Institutet för Miljömedicin, Toxikologi, Karolinska Institutet, Stockholm
visa färre...
 (creator_code:org_t)
ISBN 9789172645608
Umeå : Medicinsk biovetenskap, 2008
Engelska 104 s.
Serie: Umeå University medical dissertations, 0346-6612 ; 1192
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • Malignant pleural mesothelioma (MPM) is an aggressive, treatment-resistant tumour. Cisplatin (cis-diamminedichloroplatinum (II)) is the best single-agent chemotherapy for MPM, but platinum-based combination therapies give the best overall response rates. However, cisplatin use is limited by resistance and severe side effects. This thesis has increased the knowledge concerning cisplatin-induced cell death in MPM by describing a novel potential therapeutic target, and three novel phenotypes of cisplatin-resistance in a human MPM cell line (P31) and its cisplatin-resistant sub-line (P31res1.2). The novel potential therapeutic target, and one of the novel phenotypes, was cisplatin-resistant pro-apoptotic BH3-only proteins. In the P31 cells, cisplatin transiently increased pro-apoptotic BH3-only proteins during 6 h of exposure. This response was almost completely abrogated in the P31res1.2 cells. De-regulated caspase activity and activation was the second novel phenotype identified. The P31res1.2 cells had earlier, possibly mitochondria-independent, caspase-3 activation, increased basal caspase-3 activity and increased basal cleavage of caspase-8 and -9. Despite these differences, 6-h equitoxic cisplatin exposures rendered 50-60% of the cells apoptotic in both cell lines. The third novel phenotype was abrogated Na+K+2Cl--cotransporter (NKCC1) activity. Although NKCC1 activity was dispensable for cisplatin-induced apoptosis, balanced potassium transport activity was essential for P31 cell survival. Finally, the survival signalling protein Protein Kinase B (PKB or Akt) isoforms α and γ were constitutively activated in a PI3K-independent manner in P31 cells. In the P31res1.2 cells, PKBα and γ activities were increased, and there was PI3K-dependent activation of PKBβ. However, this increase in PKB isoform activity was not strongly associated to the cisplatin-resistance of the P31res1.2 cells.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Annan klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Other Clinical Medicine (hsv//eng)

Nyckelord

apoptosis
BH3-only proteins
caspase
cell morphology
potassium transport
protein kinase B (PKB/Akt)
signalling pathways
time
Clinical chemistry
Klinisk kemi

Publikations- och innehållstyp

vet (ämneskategori)
dok (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy